DENISE JOFFE
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism BRYN MAWR, PA NPI 1760675714
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism PA Lilly USA, LLC All categories
General Payments — all program years on this page
$8,420.44
- Category: General Payments
- Program years: PY2018–2024
- Record count: 422
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $2,305.71 across 104 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,305.71 | 104 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $412.19 | 17 |
| Novo Nordisk AS | $338.87 | 17 |
| Abbott Laboratories | $257.82 | 12 |
| Amgen Inc. | $153.03 | 8 |
| Radius Health, Inc. | $114.44 | 4 |
| Corcept Therapeutics | $113.98 | 4 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $98.14 | 5 |
| Amphastar Pharmaceuticals, Inc. | $83.32 | 5 |
| ABBVIE INC. | $80.87 | 4 |
| DEXCOM, INC. | $80.59 | 3 |
| Medtronic, Inc. | $79.73 | 3 |
| TOLMAR, INC. | $78.27 | 5 |
| Tandem Diabetes Care, Inc. | $66.68 | 2 |
| IBSA Pharma Inc. | $47.78 | 2 |
| Xeris Pharmaceuticals, Inc. | $46.34 | 2 |
| Rhythm Pharmaceuticals, Inc. | $34.93 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $31.95 | 2 |
| Ascensia Diabetes Care US Inc. | $29.37 | 1 |
| Kyowa Kirin, Inc. | $26.55 | 1 |
| SANOFI-AVENTIS U.S. LLC | $26.50 | 1 |
| Astellas Pharma US Inc | $24.17 | 1 |
| CeQur Corporation | $22.99 | 1 |
| Insulet Corporation | $21.47 | 1 |
| Almatica Pharma Inc. | $18.19 | 1 |
| Ultragenyx Pharmaceutical Inc. | $17.54 | 1 |
By program year
Records — PY2024 (104)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.